Halozyme Therapeutics Inc (HALO)

[jamtomorrow2]

HALO is hardly behaving like a share with potential PEG breakthrough information about to be released or with royalties growing at high rates on three blockbuster drugs. I have a horrible feeling that the cleaned up Phase 2 data is still going to be confusing and certainly not useable for an NDA. That means that it's going to be 2020 before the first HALO PEG product comes to market - and the likelihood is that the costs of these trials will not be covered by partnered royalties, which continue to disappoint every quarter. HALO has been a lousy investment for the past 10 years and to my mind development costs are running out of control - certainly relative to the royalty income.